---
title: "Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282205075.md"
description: "Pulse Biosciences has appointed Liane R. Teplitsky as Chief Operating Officer, effective April 8, 2026. Teplitsky has a strong background, having served as the former CEO of Artedrone and held senior roles at Abbott Laboratories and St. Jude Medical. She will also continue as Chairman of the Board of Carvolix. Further details regarding the reason for her appointment and any replacements have not been disclosed."
datetime: "2026-04-09T13:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282205075.md)
  - [en](https://longbridge.com/en/news/282205075.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282205075.md)
---

# Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences

**Pulse Biosciences appointed Liane R. Teplitsky as Chief Operating Officer, effective April 8, 2026.**

Individual

Liane R. Teplitsky

Role

Chief Operating Officer

Type of Change

Appointed

Effective Date

April 8, 2026

Reason

Not disclosed

Replacement Info

Not disclosed

Background Details

Former CEO of Artedrone; senior roles at Abbott Laboratories, St. Jude Medical; President of Robotics, Technology and Data Solutions at Zimmer Biomet; MS Biomedical Engineering (Duke); BS Electrical Engineering & Physiology (Univ. of Saskatchewan); Chairman of Carvolix

Board/Committee Role Changes

Will remain Chairman of the Board of Carvolix; no other changes disclosed

Original SEC Filing: PULSE BIOSCIENCES, INC. \[ PLSE \] - 8-K - Apr. 09, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [CVAC.US](https://longbridge.com/en/quote/CVAC.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [CRVS.US](https://longbridge.com/en/quote/CRVS.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Eton Secures U.S. IMPAVIDO Rights; $4.25M Fees, Up To $4M Milestones And 50-55% Revenue Share](https://longbridge.com/en/news/286966420.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [Shah Capital Management Will Vote ‘No' Across Five Proposals On Novavax's June 18 Ballot - SEC Filing](https://longbridge.com/en/news/286565204.md)
- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [14:05 ETLupin Receives Tentative Approval from U.S. FDA for Revefenacin Inhalation Solution](https://longbridge.com/en/news/286805922.md)